Gene therapy for rare bleeding disorder achieves proof-of-concept

Hematology researchers have used a single injection of gene therapy to correct a rare bleeding disorder, factor VII deficiency, in dogs. This success in large animals holds considerable potential for a safe, effective and long-lasting new treatment in humans with the same bleeding disorder.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1PhAlz8